These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 29906512)
1. Mechanisms of fibronectin-binding protein A (FnBPA Zhang R; Li S; Zhang XK; Wang Y; Yang LY; Zeng H; Yan DP; Zou QM; Zuo QF Clin Immunol; 2018 Sep; 194():1-8. PubMed ID: 29906512 [TBL] [Abstract][Full Text] [Related]
2. Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Joshi A; Pancari G; Cope L; Bowman EP; Cua D; Proctor RA; McNeely T Hum Vaccin Immunother; 2012 Mar; 8(3):336-46. PubMed ID: 22327491 [TBL] [Abstract][Full Text] [Related]
3. IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection. Narita K; Asano K; Nakane A Med Microbiol Immunol; 2017 Jun; 206(3):225-234. PubMed ID: 28378247 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection. Narita K; Hu DL; Asano K; Nakane A Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568 [TBL] [Abstract][Full Text] [Related]
5. Protective humoral and CD4 Yu W; Yao D; Yu S; Wang X; Li X; Wang M; Liu S; Feng Z; Chen X; Li W; Wang L; Liu W; Ma J; Yu L; Tong C; Song B; Cui Y Sci Rep; 2018 Feb; 8(1):3580. PubMed ID: 29483570 [TBL] [Abstract][Full Text] [Related]
6. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A. Mancini F; Monaci E; Lofano G; Torre A; Bacconi M; Tavarini S; Sammicheli C; Arcidiacono L; Galletti B; Laera D; Pallaoro M; Tuscano G; Fontana MR; Bensi G; Grandi G; Rossi-Paccani S; Nuti S; Rappuoli R; De Gregorio E; Bagnoli F; Soldaini E; Bertholet S PLoS One; 2016; 11(1):e0147767. PubMed ID: 26812180 [TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models. Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417 [TBL] [Abstract][Full Text] [Related]
8. A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus. Wang XY; Huang ZX; Chen YG; Lu X; Zhu P; Wen K; Fu N; Liu BY PLoS One; 2015; 10(8):e0136888. PubMed ID: 26317210 [TBL] [Abstract][Full Text] [Related]
9. A novel bivalent fusion vaccine induces broad immunoprotection against Staphylococcus aureus infection in different murine models. Yang L; Zhou H; Cheng P; Yang Y; Tong Y; Zuo Q; Feng Q; Zou Q; Zeng H Clin Immunol; 2018 Mar; 188():85-93. PubMed ID: 29289748 [TBL] [Abstract][Full Text] [Related]
10. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection. Narita K; Hu DL; Asano K; Nakane A Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736 [TBL] [Abstract][Full Text] [Related]
11. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A. Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443 [TBL] [Abstract][Full Text] [Related]
12. Induction of cell-mediated immunity to Staphylococcus aureus in the mouse mammary gland by local immunization with a live attenuated mutant. Gómez MI; Sordelli DO; Buzzola FR; García VE Infect Immun; 2002 Aug; 70(8):4254-60. PubMed ID: 12117934 [TBL] [Abstract][Full Text] [Related]
13. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms. Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ mBio; 2018 Oct; 9(5):. PubMed ID: 30327437 [No Abstract] [Full Text] [Related]
14. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. Lin L; Ibrahim AS; Xu X; Farber JM; Avanesian V; Baquir B; Fu Y; French SW; Edwards JE; Spellberg B PLoS Pathog; 2009 Dec; 5(12):e1000703. PubMed ID: 20041174 [TBL] [Abstract][Full Text] [Related]
16. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity. Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035 [TBL] [Abstract][Full Text] [Related]
17. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. Nilsson IM; Patti JM; Bremell T; Höök M; Tarkowski A J Clin Invest; 1998 Jun; 101(12):2640-9. PubMed ID: 9637697 [TBL] [Abstract][Full Text] [Related]
18. Identification of the immunodominant regions of Staphylococcus aureus fibronectin-binding protein A. Zuo QF; Cai CZ; Ding HL; Wu Y; Yang LY; Feng Q; Yang HJ; Wei ZB; Zeng H; Zou QM PLoS One; 2014; 9(4):e95338. PubMed ID: 24736634 [TBL] [Abstract][Full Text] [Related]
19. Role and plasticity of Th1 and Th17 responses in immunity to Ferraro A; Buonocore SM; Auquier P; Nicolas I; Wallemacq H; Boutriau D; van der Most RG Hum Vaccin Immunother; 2019; 15(12):2980-2992. PubMed ID: 31149870 [TBL] [Abstract][Full Text] [Related]